Straumann Group Reports 9.2% Organic Growth in Q3 2026

Straumann Group announced a 9.2% organic growth in revenue for the third quarter of 2026, reaching CHF 667.1 million. This marks an acceleration from the previous period, driven by robust demand across all regions. Revenue for the first nine months totaled CHF 2 billion, up by 8.3% organically. Both Europe, Middle East and Africa (EMEA) and Asia Pacific (APAC) regions reported double-digit growth, while North America (NAM) also saw solid performance amid a challenging market environment.

Product innovations such as the Straumann F.A.S.T. implant solutions and the SIRIOS APS full-arch scanning technology have reinforced Straumann's market position. The group's digital platform, Straumann AXS, continues to grow, enhancing customer engagement and driving recurrent sales. The company maintains its outlook for high single-digit growth for the full year 2026, expecting EBIT margin expansion by 140 to 170 basis points.